EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment near the end of life in pancreatic cancer in England

Zhe Wang, Rebecca Watters, Lorna Roden, Gurdeep Mannu, Sileida Oliveros, David Dodwell

Clinical Oncology · 2026-11 · 104366

DOI: 10.1016/j.clon.2026.104366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2026-11. Verfasst von Zhe Wang und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Management decisions when end of life is approaching are difficult and there are few studies addressing this concern using national cancer data. We conducted a retrospective population-based cohort study using linked English cancer registration, treatment and hospital records. We included 10,835 patients with pancreatic cancer who had received systemic anticancer therapy at some point, and had died during 2015-2019 and considered receipt of disease-targeted treatment (major surgery, radiotherapy or chemotherapy). Overall, 14% received chemotherapy and 2% received radiotherapy within 30 days of death. This proportion appeared stable over time. Among 8,222 patients whose treatment intent was recorded as palliative, 17.4% received systemic therapy within 30 days of death. Recent intervention was associated with multiple emergency attendances (odds ratio 1.51, 95% CI 1.27-1.79) and inpatient admissions (2.32, 2.05-2.62). These findings describe treatment intensity, not inappropriate care. Variation in care by patient, hospital and treatment factors supports analyses of patient preferences, palliative care interventions and patient-reported outcomes to inform future management. 4, 30 and 90 days of death

Förderung

  • Cancer Research UK

Zitieren

APA

Wang, Z., Watters, R., Roden, L., Mannu, G., Oliveros, S., & Dodwell, D. (2026). Treatment near the end of life in pancreatic cancer in England. Clinical Oncology, 104366. https://doi.org/10.1016/j.clon.2026.104366

Vancouver

Wang Z, Watters R, Roden L, Mannu G, Oliveros S, Dodwell D. Treatment near the end of life in pancreatic cancer in England. Clinical Oncology. 2026:104366. doi:10.1016/j.clon.2026.104366

BibTeX
@article{Wang2026,
  author = {Wang, Zhe and Watters, Rebecca and Roden, Lorna and Mannu, Gurdeep and Oliveros, Sileida and Dodwell, David},
  title = {Treatment near the end of life in pancreatic cancer in England},
  journal = {Clinical Oncology},
  year = {2026},
  pages = {104366},
  doi = {10.1016/j.clon.2026.104366}
}
Kostenlos starten →